Reference
FDA. Teligent Pharma, Inc. Issues Worldwide Voluntary Recall of Lidocaine HCl Topical Solution 4% Due to Super Potency Internet Document : 12 Oct 2021. Available from: URL: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/teligent-pharma-incs-issues-worldwide-voluntary-recall-lidocaine-hcl-topical-solution-4-due-super
Rights and permissions
About this article
Cite this article
Teligent recalls five lots of lidocaine topical solution due to potency. Reactions Weekly 1879, 5 (2021). https://doi.org/10.1007/s40278-021-04489-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-04489-7